Whether 21 U.S.C. § 841(b)(1)(C)'s death-results enhancement requires the government to prove proximate causation in addition to but-for causation.
Holding
No. Section 841(b)(1)(C) requires but-for causation, but it does not impose a separate proximate-cause or foreseeability requirement.
Reasoning
The statutory phrase is triggered when “death or serious bodily injury results from the use of” the controlled substance. Following Burrage v. United States, the court read “results from” according to its ordinary meaning: death must arise as an effect or outcome of the drug’s use. That language requires actual, or but-for, causation—meaning the death would not have occurred without the drug’s incremental effect—but does not itself add a proximate-cause requirement.
The relevant causal relationship is between the victim’s use of the controlled substance and the victim’s death, not between the defendant’s broader drug-distribution conduct and the death. Jeffries’s proposed instruction instead would have required proof that death was a natural and foreseeable result of his own actions. The court held that this reframed the statutory inquiry and conflicted with the provision’s structure.
The broader statutory setting confirmed that reading. Section 841(a)(1) criminalizes knowing or intentional drug distribution and related conduct, while § 841(b)(1)(C) supplies the penalty when death results from use of the distributed drug. Because Schedule I and II controlled substances are inherently dangerous, death or injury from their use is not a consequence so attenuated from drug distribution that ordinary proximate-cause limits are necessary to prevent liability based on mere fortuity.
Traditional criminal-law principles generally treat causation as including both actual and legal, or proximate, cause. But those background principles apply only when Congress has not spoken directly. Here, Congress directly tied the enhanced penalty to death resulting from use of the controlled substance, and the court found that wording unambiguous. It therefore declined to insert an additional proximate-cause element.
Burrage did not resolve the proximate-cause question, but it supported the court’s textual approach. Burrage held that § 841(b)(1)(C) requires but-for causation and rejected a mere contributing-cause standard. Its use of other interpretive sources reinforced its ordinary-meaning conclusion; it did not establish that the statute was ambiguous or that the rule of lenity supplied an additional proximate-cause requirement.
The court also distinguished United States v. Martinez, which applied proximate cause to a similar death-results provision in the health-care-fraud statute. Health-care fraud encompasses conduct that often has no inherent connection to physical injury or death, whereas § 841(b)(1)(C) specifically concerns death resulting from use of a dangerous controlled substance. Moreover, Martinez reviewed whether evidence was sufficient under jury instructions that had already required proximate cause; it did not decide that proximate cause was the minimum statutory requirement in every death-results provision.
Finally, § 841(b)(1)(C) is not a strict-liability criminal offense merely because its enhancement has no separate mens rea as to death. The underlying § 841(a)(1) offense requires the government to prove that the defendant knowingly or intentionally committed the prohibited drug conduct. The death-results finding elevates the penalty for that knowing or intentional offense.